Natasha N. Campbell

Array ( [id] => 8465635 [patent_doc_number] => 20120270804 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'METHODS FOR THE TREATMENT AND PREVENTION OF OCULAR DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/458460 [patent_app_country] => US [patent_app_date] => 2012-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17285 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13458460 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8359588 [patent_doc_number] => 20120214749 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-23 [patent_title] => 'MICROPARTICLES COMPRISING SOMATOSTATIN ANALOGUES' [patent_app_type] => utility [patent_app_number] => 13/456681 [patent_app_country] => US [patent_app_date] => 2012-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7700 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13456681 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9491792 [patent_doc_number] => 20140142198 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-22 [patent_title] => 'CROSS-LINKED POLY-E-LYSINE NON-PARTICULATE SUPPORT' [patent_app_type] => utility [patent_app_number] => 14/112742 [patent_app_country] => US [patent_app_date] => 2012-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9259 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14112742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9355328 [patent_doc_number] => 08673861 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-18 [patent_title] => 'Tissue protective peptides and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/448345 [patent_app_country] => US [patent_app_date] => 2012-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 16 [patent_no_of_words] => 31432 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13448345 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10032659 [patent_doc_number] => 09073965 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-07 [patent_title] => 'Adiponectin receptor agonists and methods of use' [patent_app_type] => utility [patent_app_number] => 14/110813 [patent_app_country] => US [patent_app_date] => 2012-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 21657 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 209 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14110813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9511862 [patent_doc_number] => 20140148355 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-29 [patent_title] => 'COMPOSITIONS AND METHODS FOR ANALYSIS OF H3K4 METHYLATED CHROMATIN' [patent_app_type] => utility [patent_app_number] => 14/007677 [patent_app_country] => US [patent_app_date] => 2012-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17426 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14007677 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8995009 [patent_doc_number] => 08518893 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-27 [patent_title] => 'Medical compositions containing ghrelin' [patent_app_type] => utility [patent_app_number] => 13/413581 [patent_app_country] => US [patent_app_date] => 2012-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 12302 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13413581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8477739 [patent_doc_number] => 20120277146 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-01 [patent_title] => 'Compounds For Enzyme Inhibition' [patent_app_type] => utility [patent_app_number] => 13/411044 [patent_app_country] => US [patent_app_date] => 2012-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20752 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13411044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8324338 [patent_doc_number] => 20120196749 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-02 [patent_title] => 'Cyclosporin Derivatives' [patent_app_type] => utility [patent_app_number] => 13/397256 [patent_app_country] => US [patent_app_date] => 2012-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8199 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13397256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10089045 [patent_doc_number] => 09125847 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-08 [patent_title] => 'A-β immunogenic peptide carrier conjugates and methods of producing same' [patent_app_type] => utility [patent_app_number] => 13/396543 [patent_app_country] => US [patent_app_date] => 2012-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 25399 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13396543 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10635608 [patent_doc_number] => 09353100 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-31 [patent_title] => 'Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating HCV infections' [patent_app_type] => utility [patent_app_number] => 13/370198 [patent_app_country] => US [patent_app_date] => 2012-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63615 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13370198 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8586824 [patent_doc_number] => 20130005644 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-03 [patent_title] => 'CYCLIC AGONISTS AND ANTAGONISTS OF C5A RECEPTORS AND G PROTEIN-COUPLED RECEPTORS' [patent_app_type] => utility [patent_app_number] => 13/348869 [patent_app_country] => US [patent_app_date] => 2012-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 11507 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13348869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9944230 [patent_doc_number] => 08993531 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-31 [patent_title] => 'PKD ligands and polynucleotides encoding PKD ligands' [patent_app_type] => utility [patent_app_number] => 13/348515 [patent_app_country] => US [patent_app_date] => 2012-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 52 [patent_no_of_words] => 7147 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 673 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13348515 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8173589 [patent_doc_number] => 20120108522 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'HDAC INHIBITORS AND HORMONE TARGETED DRUGS FOR THE TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 13/343299 [patent_app_country] => US [patent_app_date] => 2012-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 24977 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20120108522.pdf [firstpage_image] =>[orig_patent_app_number] => 13343299 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8160105 [patent_doc_number] => 20120101025 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-26 [patent_title] => 'Compounds For Enzyme Inhibition' [patent_app_type] => utility [patent_app_number] => 13/341022 [patent_app_country] => US [patent_app_date] => 2011-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26892 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20120101025.pdf [firstpage_image] =>[orig_patent_app_number] => 13341022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8160107 [patent_doc_number] => 20120101026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-26 [patent_title] => 'Compounds For Enzyme Inhibition' [patent_app_type] => utility [patent_app_number] => 13/341056 [patent_app_country] => US [patent_app_date] => 2011-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26907 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20120101026.pdf [firstpage_image] =>[orig_patent_app_number] => 13341056 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10114580 [patent_doc_number] => 09149444 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-06 [patent_title] => 'Modulation of synaptic maintenance' [patent_app_type] => utility [patent_app_number] => 13/326180 [patent_app_country] => US [patent_app_date] => 2011-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16030 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13326180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8429570 [patent_doc_number] => 20120251445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-04 [patent_title] => 'PEPTIDES WHOSE UPTAKE BY CELLS IS CONTROLLABLE' [patent_app_type] => utility [patent_app_number] => 13/314134 [patent_app_country] => US [patent_app_date] => 2011-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 13745 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13314134 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9455239 [patent_doc_number] => 08716247 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-06 [patent_title] => 'Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells' [patent_app_type] => utility [patent_app_number] => 13/305143 [patent_app_country] => US [patent_app_date] => 2011-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17619 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13305143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9355331 [patent_doc_number] => 08673863 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-18 [patent_title] => 'Glutathione-based delivery system' [patent_app_type] => utility [patent_app_number] => 13/287480 [patent_app_country] => US [patent_app_date] => 2011-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4127 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13287480 [rel_patent_id] =>[rel_patent_doc_number] =>)